Treace Medical Concepts, Inc.
David Pidgeon, MBA has had an extensive work experience in various roles and industries. David currently serves as the Director of Operations at Treace Medical Concepts, Inc. since September 2022. Prior to that, they worked as the Director, Consumable Equipment Supply Chain at STERIS from November 2021 to July 2022.
Before joining STERIS, David held senior managerial positions at Cantel, A STERIS Company, including Sr Manager, Planning from August 2020 to November 2021, and Production Planning Manager from May 2019 to August 2020.
David also has experience as a Co-Owner/COO at RTF LLC from June 2018 to April 2019. Earlier in their career, they worked at Ecolab, where they took on multiple roles such as Supply Planning Manager from February 2017 to October 2018, Production Manager from January 2015 to February 2017, Production Planner II from June 2014 to December 2014, Production Planner I from June 2013 to June 2014, Production Supervisor from January 2012 to June 2013, and Corporate Engineer from April 2010 to January 2012.
David'sinitial work experience includes roles as a Chemical Engineering Research Assistant at Orbital Technologies from August 2008 to January 2009, and as a Chemical Engineering Optimization Intern at Flint Hills Resources from May 2008 to August 2008.
David Pidgeon, MBA, has a diverse education history. David earned their Executive MBA (CEMBA) from the University of Minnesota - Carlson School of Management from 2020 to 2022. Prior to that, they attended the University of Wisconsin-Madison from 2007 to 2009, where they received Bachelor's of Science degrees in Chemical and Biological Engineering and Chemistry. In 2004 to 2006, David attended the University of Illinois Urbana-Champaign, although no specific degree or field of study information is provided for this period.
This person is not in any teams
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.